FORMOTEROL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Formoterol, and what generic alternatives are available?
Formoterol is a drug marketed by Alembic, Deva Holding As, Dr Reddys, Lexenpharm, Lupin, Mankind Pharma, Micro Labs, Ritedose Corp, Teva Pharms Usa Inc, and Wilshire Pharms Inc. and is included in ten NDAs.
The generic ingredient in FORMOTEROL is formoterol fumarate. There are nineteen drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the formoterol fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Formoterol
A generic version of FORMOTEROL was approved as formoterol fumarate by TEVA PHARMS USA INC on June 22nd, 2021.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FORMOTEROL?
- What are the global sales for FORMOTEROL?
- What is Average Wholesale Price for FORMOTEROL?
Summary for FORMOTEROL
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 10 |
| Drug Prices: | Drug price information for FORMOTEROL |
| DailyMed Link: | FORMOTEROL at DailyMed |
US Patents and Regulatory Information for FORMOTEROL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 215078-001 | Nov 22, 2021 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Micro Labs | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 218304-001 | Jun 26, 2024 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Lexenpharm | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 216426-001 | Oct 22, 2024 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ritedose Corp | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 216486-001 | Nov 25, 2022 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Deva Holding As | FORMOTEROL FUMARATE | formoterol fumarate | SOLUTION;INHALATION | 218308-001 | Feb 11, 2025 | AN | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
